Trinity Biotech Plc (TRIB)
0.688
-0.02
(-3.08%)
USD |
NASDAQ |
Jan 16, 16:00
0.6999
+0.01
(+1.73%)
After-Hours: 20:00
Trinity Biotech Shareholders Equity (Quarterly): -54.72M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amarin Corp. Plc | 458.89M |
| DBV Technologies SA | 52.85M |
| Ascendis Pharma A/S | -204.54M |
| Cellectis SA | 100.48M |
| Akari Therapeutics Plc | 22.69M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 103.71M |
| Total Liabilities (Quarterly) | 158.43M |
| Debt to Equity Ratio | -2.142 |
| Current Ratio | 1.030 |
| Net Debt Paydown Yield | -24.64% |